These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37558937)

  • 21. A review on computer-aided chemogenomics and drug repositioning for rational COVID-19 drug discovery.
    Maghsoudi S; Taghavi Shahraki B; Rameh F; Nazarabi M; Fatahi Y; Akhavan O; Rabiee M; Mostafavi E; Lima EC; Saeb MR; Rabiee N
    Chem Biol Drug Des; 2022 Nov; 100(5):699-721. PubMed ID: 36002440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How polypharmacologic is each chemogenomics library?
    Ni E; Kwon E; Young LM; Felsovalyi K; Fuller J; Cardozo T
    Future Drug Discov; 2020 Feb; 2(1):FDD26. PubMed ID: 32149277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.
    Pasquer QTL; Tsakoumagkos IA; Hoogendoorn S
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TDR Targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration.
    Urán Landaburu L; Berenstein AJ; Videla S; Maru P; Shanmugam D; Chernomoretz A; Agüero F
    Nucleic Acids Res; 2020 Jan; 48(D1):D992-D1005. PubMed ID: 31680154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles.
    Thomas JR; Shelton C; Murphy J; Brittain S; Bray MA; Aspesi P; Concannon J; King FJ; Ihry RJ; Ho DJ; Henault M; Hadjikyriacou A; Neri M; Sigoillot FD; Pham HT; Shum M; Barys L; Jones MD; Martin EJ; Blechschmidt A; Rieffel S; Troxler TJ; Mapa FA; Jenkins JL; Jain RK; Kutchukian PS; Schirle M; Renner S
    ACS Chem Biol; 2024 Apr; 19(4):938-952. PubMed ID: 38565185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint.
    Bender A; Young DW; Jenkins JL; Serrano M; Mikhailov D; Clemons PA; Davies JW
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):719-31. PubMed ID: 18045083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
    Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
    AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target identification for biologically active small molecules using chemical biology approaches.
    Lee H; Lee JW
    Arch Pharm Res; 2016 Sep; 39(9):1193-201. PubMed ID: 27387321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iconix Pharmaceuticals, Inc.--removing barriers to efficient drug discovery through chemogenomics.
    Engelberg A
    Pharmacogenomics; 2004 Sep; 5(6):741-4. PubMed ID: 15335294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinatorial informatics in the post-genomics ERA.
    Agrafiotis DK; Lobanov VS; Salemme FR
    Nat Rev Drug Discov; 2002 May; 1(5):337-46. PubMed ID: 12120409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting trypanosomes: how chemogenomics and artificial intelligence can guide drug discovery.
    Urán Landaburu L; Didier Garnham M; Agüero F
    Biochem Soc Trans; 2023 Feb; 51(1):195-206. PubMed ID: 36606702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical genomics: a systematic approach in biological research and drug discovery.
    Zheng XF; Chan TF
    Curr Issues Mol Biol; 2002 Apr; 4(2):33-43. PubMed ID: 11931568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. StemCellCKB: An Integrated Stem Cell-Specific Chemogenomics KnowledgeBase for Target Identification and Systems-Pharmacology Research.
    Zhang Y; Wang L; Feng Z; Cheng H; McGuire TF; Ding Y; Cheng T; Gao Y; Xie XQ
    J Chem Inf Model; 2016 Oct; 56(10):1995-2004. PubMed ID: 27643925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemogenomics and biotechnology.
    Wuster A; Madan Babu M
    Trends Biotechnol; 2008 May; 26(5):252-8. PubMed ID: 18346803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative chemogenomics: machine-learning models of protein-ligand interaction.
    Andersson CR; Gustafsson MG; Strömbergsson H
    Curr Top Med Chem; 2011; 11(15):1978-93. PubMed ID: 21470169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2008 Dec; 3(12):1371-6. PubMed ID: 23506102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of combinatorial library methods in cancer research and drug discovery.
    Lam KS
    Anticancer Drug Des; 1997 Apr; 12(3):145-67. PubMed ID: 9154108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding chemogenomic space using chemoproteomics.
    Jones LH
    Bioorg Med Chem; 2019 Aug; 27(15):3451-3453. PubMed ID: 31221609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Drug Interactions From Chemogenomics Using INDIGO.
    Chandrasekaran S
    Methods Mol Biol; 2019; 1888():219-231. PubMed ID: 30519950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.